Sinopharm Animal Protection strives to build an internal control management system

2022 is the year of strengthening the compliance management of Sinopharm Group and China Biotechnology. Sinopharm Animal Health responded positively to the work deployment, acted quickly, and launched a “compliance risk list as the basis, compliance management system and operating rules as the guarantee, compliance and internal control manual as the core, and special compliance guidelines as the extension”. Establishment of internal control management system and compilation of internal control manual.

The company has established a risk internal control team coordinated by financial, legal, audit and business personnel. Based on the reference and study of the internal control manuals of China Biotechnology and other brother units, combined with the actual situation, in accordance with the five elements of internal control, the team covers strategic planning, human resources, capital, procurement, fixed assets and intangible assets, sales, scientific research, engineering projects, In 18 areas, including financial reports, overall budgets, contracts, production, storage and transportation, quality, equity investment, taxation, costs and expenses, and internal auditing, we started to carry out internal control research and manual compilation. The members of the team earnestly study the knowledge of internal control and risk management, go deep into the front line of business, understand the actual situation of the company's various businesses, and based on the company's existing system, actively provide advice and suggestions in the aspects of risk point identification, internal control process sorting, and control measure design.

The risk internal control team divided the work of 18 internal control manuals according to the business content, and worked out a timetable. Formulate business frameworks, business processes, and related work involving rules and regulations and forms. At present, the group has conducted 7 intensive discussions, effectively coordinating and coordinating compliance, law, risk control, internal control, and internal audit, and unified and clarified the common problems in the manual compilation process.

As of the end of May, the company has preliminarily prepared the first drafts of 18 internal control manuals, and is soliciting opinions from within the company. The internal control manual will clarify the internal control management responsibilities and daily business processes of the company's various departments and business operators, which can better promote the company to form a closed loop of compliance management, and initially establish a "horizontal to edge, vertical to bottom" internal control risk management system , to achieve the management and control goals of "strengthening internal control, preventing risks, and promoting compliance".

Sinopharm Animal Insurance launched special training on procurement business compliance

Sinopharm Animal Insurance held a sales prospect meeting in the first half of 2022

RELATED INFORMATION